Search

Joshua D. Zimmerman

Examiner (ID: 18702, Phone: (571)272-2749 , Office: P/2854 )

Most Active Art Unit
2854
Art Unit(s)
2854, 2853
Total Applications
1009
Issued Applications
423
Pending Applications
74
Abandoned Applications
526

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18178915 [patent_doc_number] => 20230039644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => EFFICIENT GENE DELIVERY TOOL WITH A WIDE THERAPEUTIC MARGIN [patent_app_type] => utility [patent_app_number] => 17/787296 [patent_app_country] => US [patent_app_date] => 2020-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5807 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17787296 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/787296
Efficient gene delivery tool with a wide therapeutic margin Dec 16, 2020 Issued
Array ( [id] => 16948054 [patent_doc_number] => 20210206745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => SALT FORMS AND POLYMORPHS OF (R)-1-(4-(6-(2-(4-(3,3-DIFLUOROCYCLOBUTOXY)-6-METHYLPYRIDIN-2-YL)ACETAMIDO) PYRIDAZIN-3-YL)-2-FLUOROBUTYL)-N-METHYL-1H-1,2,3-TRIAZOLE-4-CARBOXAMIDE [patent_app_type] => utility [patent_app_number] => 17/124051 [patent_app_country] => US [patent_app_date] => 2020-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19064 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17124051 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/124051
Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide Dec 15, 2020 Issued
Array ( [id] => 18574312 [patent_doc_number] => 11730818 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-22 [patent_title] => Degradation of Bruton's tyrosine kinase (BTK) by conjugation of BTK inhibitors with E3 ligase ligand and methods of use [patent_app_type] => utility [patent_app_number] => 17/123955 [patent_app_country] => US [patent_app_date] => 2020-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 46476 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17123955 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/123955
Degradation of Bruton's tyrosine kinase (BTK) by conjugation of BTK inhibitors with E3 ligase ligand and methods of use Dec 15, 2020 Issued
Array ( [id] => 18141752 [patent_doc_number] => 20230015595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-19 [patent_title] => USE OF VALPROIC ACID FOR REDUCING POST-OPERATIVE SCARRING FOLLOWING A GLAUCOMA SURGERY [patent_app_type] => utility [patent_app_number] => 17/783185 [patent_app_country] => US [patent_app_date] => 2020-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6667 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17783185 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/783185
USE OF VALPROIC ACID FOR REDUCING POST-OPERATIVE SCARRING FOLLOWING A GLAUCOMA SURGERY Dec 10, 2020 Pending
Array ( [id] => 17214426 [patent_doc_number] => 20210347763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => BIARYL PIPERIDINE AMIDE COMPOUNDS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/114699 [patent_app_country] => US [patent_app_date] => 2020-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19548 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17114699 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/114699
BIARYL PIPERIDINE AMIDE COMPOUNDS AND METHODS OF USE THEREOF Dec 7, 2020 Abandoned
Array ( [id] => 18287331 [patent_doc_number] => 20230102803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => DIETARY BUTYRATE AND ITS USES [patent_app_type] => utility [patent_app_number] => 17/756871 [patent_app_country] => US [patent_app_date] => 2020-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8365 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17756871 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/756871
Dietary butyrate and its uses Dec 3, 2020 Issued
Array ( [id] => 18107882 [patent_doc_number] => 20230000762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => INJECTABLE HYDROGELS FOR CELL DELIVERY TO THE VITREOUS [patent_app_type] => utility [patent_app_number] => 17/781076 [patent_app_country] => US [patent_app_date] => 2020-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23778 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781076 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/781076
Injectable hydrogels for cell delivery to the vitreous Dec 2, 2020 Issued
Array ( [id] => 18181383 [patent_doc_number] => 20230042112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => A Process For Preparing Isoindolinone Derivative, Novel Intermediates Used For The Process, And A Process For Preparing The Intermediates [patent_app_type] => utility [patent_app_number] => 17/782500 [patent_app_country] => US [patent_app_date] => 2020-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3178 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782500 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/782500
Process for preparing isoindolinone derivative, novel intermediates used for the process, and a process for preparing the intermediates Dec 2, 2020 Issued
Array ( [id] => 20592320 [patent_doc_number] => 12576016 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-17 [patent_title] => Composition containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one, a preservative and/or antioxidant, a surfactant and a polymer, and the method for processing keratin materials from the composition [patent_app_type] => utility [patent_app_number] => 17/781428 [patent_app_country] => US [patent_app_date] => 2020-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18610 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 300 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781428 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/781428
Composition containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one, a preservative and/or antioxidant, a surfactant and a polymer, and the method for processing keratin materials from the composition Dec 1, 2020 Issued
Array ( [id] => 18222089 [patent_doc_number] => 20230061083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => KRAS G12C INHIBITOR COMPOUND AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/779684 [patent_app_country] => US [patent_app_date] => 2020-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32687 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17779684 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/779684
KRAS G12C INHIBITOR COMPOUND AND USE THEREOF Nov 26, 2020 Abandoned
Array ( [id] => 16976127 [patent_doc_number] => 20210220364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => COMBINATION THERAPY INVOLVING DIARYL MACROCYCLIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/104752 [patent_app_country] => US [patent_app_date] => 2020-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30979 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17104752 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/104752
Combination therapy involving diaryl macrocyclic compounds Nov 24, 2020 Issued
Array ( [id] => 16711807 [patent_doc_number] => 20210078954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => GUANIDYL-CONTAINING P2Y12 RECEPTOR ANTAGONIST AND PREPARATION METHOD AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/105445 [patent_app_country] => US [patent_app_date] => 2020-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7660 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 484 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17105445 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/105445
Guanidyl-containing P2Y12 receptor antagonist and preparation method and application thereof Nov 24, 2020 Issued
Array ( [id] => 18399298 [patent_doc_number] => 11661424 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-30 [patent_title] => Process for preparing BTK inhibitors [patent_app_type] => utility [patent_app_number] => 17/102086 [patent_app_country] => US [patent_app_date] => 2020-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 34518 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17102086 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/102086
Process for preparing BTK inhibitors Nov 22, 2020 Issued
Array ( [id] => 18216392 [patent_doc_number] => 11591314 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-28 [patent_title] => Process for preparing tetrahydrocarbazole carboxamide compound [patent_app_type] => utility [patent_app_number] => 17/101411 [patent_app_country] => US [patent_app_date] => 2020-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17983 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17101411 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/101411
Process for preparing tetrahydrocarbazole carboxamide compound Nov 22, 2020 Issued
Array ( [id] => 18056583 [patent_doc_number] => 20220387669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => CONTROLLED-VISCOSITY POLYMERIC HYDROGEL AND METHOD FOR MAKING IT [patent_app_type] => utility [patent_app_number] => 17/775779 [patent_app_country] => US [patent_app_date] => 2020-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1708 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17775779 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/775779
CONTROLLED-VISCOSITY POLYMERIC HYDROGEL AND METHOD FOR MAKING IT Nov 18, 2020 Pending
Array ( [id] => 16807777 [patent_doc_number] => 20210130330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => SOLID FORMS OF CERDULATINIB [patent_app_type] => utility [patent_app_number] => 17/098852 [patent_app_country] => US [patent_app_date] => 2020-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44566 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098852 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/098852
Solid forms of Cerdulatinib Nov 15, 2020 Issued
Array ( [id] => 16807777 [patent_doc_number] => 20210130330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => SOLID FORMS OF CERDULATINIB [patent_app_type] => utility [patent_app_number] => 17/098852 [patent_app_country] => US [patent_app_date] => 2020-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44566 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098852 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/098852
Solid forms of Cerdulatinib Nov 15, 2020 Issued
Array ( [id] => 16807777 [patent_doc_number] => 20210130330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => SOLID FORMS OF CERDULATINIB [patent_app_type] => utility [patent_app_number] => 17/098852 [patent_app_country] => US [patent_app_date] => 2020-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44566 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098852 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/098852
Solid forms of Cerdulatinib Nov 15, 2020 Issued
Array ( [id] => 18887665 [patent_doc_number] => 11866426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-09 [patent_title] => Benzothiazole compounds and uses thereof [patent_app_type] => utility [patent_app_number] => 17/098880 [patent_app_country] => US [patent_app_date] => 2020-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31173 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 3969 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098880 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/098880
Benzothiazole compounds and uses thereof Nov 15, 2020 Issued
Array ( [id] => 16807777 [patent_doc_number] => 20210130330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => SOLID FORMS OF CERDULATINIB [patent_app_type] => utility [patent_app_number] => 17/098852 [patent_app_country] => US [patent_app_date] => 2020-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44566 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098852 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/098852
Solid forms of Cerdulatinib Nov 15, 2020 Issued
Menu